← Eichor
Condition: Gastric Malt Lymphoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Gastric Malt Lymphoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Phase N/A · 68 location(s) · Massive Bio, Inc. · NCT03452774Cohort Study for Gastric MALT Lymphoma
Phase N/A · 3 location(s) · Seoul National University Hospital · NCT06454149Orelabrutinib in the Treatment of HP-positive Gastric MALT Lymphoma
Phase 2 · 1 location(s) · Fudan University · NCT06228963ISRT 20 Gy for Indolent Localized Gastrointestinal (GI)-Lymphoma
NA · 1 location(s) · University Hospital Muenster · NCT04097067Study of SGR-1505 in Mature B-Cell Neoplasms
Phase 1 · 36 location(s) · Schrödinger, Inc. · NCT05544019SynKIR-310 for Relapsed/Refractory B-NHL
Phase 1 · 5 location(s) · Verismo Therapeutics · NCT06544265
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.